Poor association between dihydropyrimidine dehydrogenase (DPYD) genotype and fluoropyrimidine‐induced toxicity in an Asian population

Authors: Kanai, Masashi, Kawaguchi, Takahisa, Kotaka, Masahito, Manaka, Dai, Hasegawa, Junichi, Takagane, Akinori, Munemoto, Yoshinori, Kato, Takeshi, Eto, Tetsuya, Touyama, Tetsuo, Matsui, Takanori, Shinozaki, Katsunori, Matsumoto, Shigemi, Mizushima, Tsunekazu, Mori, Masaki, Sakamoto, Junichi, Ohtsu, Atsushi, Yoshino, Takayuki, Saji, Shigetoyo, Matsuda, Fumihiko

Source: Cancer medicine. 12(7):7808-7814

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100187356219.0x000001&indx=1&recIds=ETOCvdc_100187356219.0x000001

Clinical implications of using both fluoropyrimidine and paclitaxel in patients with severe peritoneal metastasis of gastric cancer: A post hoc study of JCOG1108/WJOG7312G

Authors: Arai, Hiroyuki, Inoue, Eisuke, Yamaguchi, Kensei, Boku, Narikazu, Hara, Hiroki, Nishina, Tomohiro, Tsuda, Masahiro, Shitara, Kohei, Shinozaki, Katsunori, Nakamura, Shinichiro, Hyodo, Ichinosuke, Muro, Kei, Sasako, Mitsuru, Terashima, Masanori, Nakajima, Takako E.

Source: Cancer medicine. 10(21):7673-7682

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100132963720.0x000001&indx=1&recIds=ETOCvdc_100132963720.0x000001

Oxaliplatin Added to Fluoropyrimidine/Bevacizumab as Initial Therapy for Unresectable Metastatic Colorectal Cancer in Older Patients: A Multicenter, Randomized, Open-Label Phase III Trial (JCOG1018).

Authors: Takashima, Atsuo, Hamaguchi, Tetsuya, Mizusawa, Junki, Nagashima, Fumio, Ando, Masahiko, Ojima, Hitoshi, Denda, Tadamichi, Watanabe, Jun, Shinozaki, Katsunori, Baba, Hideo, Asayama, Masako, Hasegawa, Seiji, Masuishi, Toshiki, Nakata, Ken, Tsukamoto, Shunsuke, Katayama, Hiroshi, Nakamura, Kenichi, Fukuda, Haruhiko, Kanemitsu, Yukihide, Shimada, Yasuhiro

Source: Journal of Clinical Oncology; 11/20/2024, Vol. 42 Issue 33, p3967-3976, 11p

Randomised phase II study of panitumumab plus irinotecan versus cetuximab plus irinotecan in patients with KRAS wild-type metastatic colorectal cancer refractory to fluoropyrimidine, irinotecan and oxaliplatin (WJOG 6510G)

Authors: Sakai, Daisuke, Taniguchi, Hiroya, Sugimoto, Naotoshi, Tamura, Takao, Nishina, Tomohiro, Hara, Hiroki, Esaki, Taito, Denda, Tadamichi, Sakamoto, Takeshi, Okuda, Hiroyuki, Satoh, Taroh, Tsushima, Takahiro, Makiyama, Akitaka, Tsuda, Takashi, Hosokawa, Ayumu, Kuramochi, Hidekazu, Tokunaga, Shinya, Moriwaki, Toshikazu, Yasui, Hisateru, Ishida, Hiroyasu, Tsuji, Akihito, Otsu, Satoshi, Shimokawa, Hozumi, Baba, Eishi, Sato, Mikio, Matsumoto, Shigemi, Ozaki, Yukinori, Shinozaki, Katsunori, Tamagawa, Hiroshi, Goto, Masahiro, Kadowaki, Shigenori, Fujii, Hirofumi, Koh, Yasuhiro, Yamazaki, Kentaro, Hironaka, Shuichi, Kishimoto, Junji, Boku, Narikazu, Hyodo, Ichinosuke, Muro, Kei

Source: In European Journal of Cancer August 2020 135:11-21

A placebo-controlled, double-blind, randomized study of recombinant thrombomodulin (ART-123) to prevent oxaliplatin-induced peripheral neuropathy

Authors: Kotaka, Masahito, Saito, Yoji, Kato, Takeshi, Satake, Hironaga, Makiyama, Akitaka, Tsuji, Yasushi, Shinozaki, Katsunori, Fujiwara, Toshiyoshi, Mizushima, Tsunekazu, Harihara, Yasushi, Nagata, Naoki, Kurihara, Naoto, Ando, Masahiko, Kusakawa, Genichi, Sakai, Takumi, Uchida, Yugo, Takamoto, Mikihiro, Kimoto, Saki, Hyodo, Ichinosuke

Source: Cancer chemotherapy and pharmacology. 86(5):607-618

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100183671971.0x000001&indx=1&recIds=ETOCvdc_100183671971.0x000001

Multicenter phase II study of SOX plus trastuzumab for patients with HER2+ metastatic or recurrent gastric cancer: KSCC/HGCSG/CCOG/PerSeUS 1501B

Authors: Yuki, Satoshi, Shinozaki, Katsunori, Kashiwada, Tomomi, Kusumoto, Tetsuya, Iwatsuki, Masaaki, Satake, Hironaga, Kobayashi, Kazuma, Esaki, Taito, Nakashima, Yuichiro, Kawanaka, Hirofumi, Emi, Yasunori, Komatsu, Yoshito, Shimokawa, Mototsugu, Makiyama, Akitaka, Saeki, Hiroshi, Oki, Eiji, Baba, Hideo, Mori, Masaki

Source: Cancer chemotherapy and pharmacology. 85(1):217-223

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100161798322.0x000001&indx=1&recIds=ETOCvdc_100161798322.0x000001

Randomized phase II/III study of 5-fluorouracil/l-leucovorin versus 5-fluorouracil/l-leucovorin plus paclitaxel administered to patients with severe peritoneal metastases of gastric cancer (JCOG1108/WJOG7312G)

Authors: Nakajima, Takako Eguchi, Yamaguchi, Kensei, Boku, Narikazu, Hyodo, Ichinosuke, Mizusawa, Junki, Hara, Hiroki, Nishina, Tomohiro, Sakamoto, Takeshi, Shitara, Kohei, Shinozaki, Katsunori, Katayama, Hiroshi, Nakamura, Shinichiro, Muro, Kei, Terashima, Masanori

Source: Gastric cancer. 23(4):677-688

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100168179485.0x000001&indx=1&recIds=ETOCvdc_100168179485.0x000001

Real-world treatment costs of first-line treatment for metastatic colorectal cancer: a survey of the JCOG colorectal cancer study group.

Authors: Takashima, Atsuo, Ishiguro, Megumi, Sasaki, Keita, Machida, Ryunosuke, Nagashima, Fumio, Imaizumi, Jun, Hamaguchi, Tetsuya, Yamamoto, Yoshiyuki, Masuishi, Toshiki, Asayama, Masako, Ueno, Hideki, Shinozaki, Katsunori, Kudo, Toshihiro, Machida, Nozomu, Matsuoka, Hiroshi, Ishida, Hideyuki, Yamaguchi, Toshifumi, Nogami, Hitoshi, Yamada, Takeshi, Takegawa, Naoki

Source: Japanese Journal of Clinical Oncology; Oct2024, Vol. 54 Issue 10, p1107-1114, 8p

Treatment outcomes according to the macroscopic tumor type in locally advanced esophageal squamous cell carcinoma treated by chemoradiotherapy

Authors: Kubo, Katsumaro, Wadasaki, Koichi, Shinozaki, Katsunori

Source: Japanese journal of radiology. 37(4):341-349

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100124957785.0x000001&indx=1&recIds=ETOCvdc_100124957785.0x000001

JOIN trial: treatment outcome and recovery status of peripheral sensory neuropathy during a 3-year follow-up in patients receiving modified FOLFOX6 as adjuvant treatment for stage II/III colon cancer

Authors: Yoshino, Takayuki, Kotaka, Masahito, Shinozaki, Katsunori, Touyama, Tetsuo, Manaka, Dai, Matsui, Takanori, Ishigure, Kiyoshi, Hasegawa, Junichi, Inoue, Keiji, Munemoto, Yoshinori, Takagane, Akinori, Ishikawa, Hiroshi, Ishida, Hideyuki, Ogata, Yutaka, Oba, Koji, Goto, Koichi, Sakamoto, Junichi, Maehara, Yoshihiko, Ohtsu, Atsushi

Source: Cancer chemotherapy and pharmacology. 84(6):1269-1277

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100125510372.0x000001&indx=1&recIds=ETOCvdc_100125510372.0x000001

Sinusoidal obstruction syndrome post-treatment with trastuzumab emtansine (T-DM1) in advanced breast cancer

Authors: Fujii, Yasutoshi, Doi, Mihoko, Tsukiyama, Naofumi, Hattori, Yui, Ohya, Kazuki, Shiroma, Noriyuki, Morio, Kei, Morioka, Takehiko, Aikata, Hiroshi, Shinozaki, Katsunori, Chayama, Kazuaki

Source: International cancer conference journal. 9(1):18-23

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100129494463.0x000001&indx=1&recIds=ETOCvdc_100129494463.0x000001

Five-weekly S-1 plus cisplatin therapy combined with trastuzumab therapy in HER2-positive gastric cancer: a phase II trial and biomarker study (WJOG7212G)

Authors: Miura, Yuji, Sukawa, Yasutaka, Hironaka, Shuichi, Mori, Misuzu, Nishikawa, Kazuhiro, Tokunaga, Shinya, Okuda, Hiroyuki, Sakamoto, Takeshi, Taku, Keisei, Nishikawa, Kazuo, Moriwaki, Toshikazu, Negoro, Yuji, Kimura, Yutaka, Uchino, Keita, Shinozaki, Katsunori, Shinozaki, Hiroharu, Musha, Nobuyuki, Yoshiyama, Hirotsugu, Tsuda, Takashi, Miyata, Yoshinori, Sugimoto, Naotoshi, Shirakawa, Tsuyoshi, Ito, Miki, Yonesaka, Kimio, Yoshimura, Kenichi, Boku, Narikazu, Nosho, Katsuhiko, Takano, Toshimi, Hyodo, Ichinosuke

Source: Gastric cancer. 21(1):84-95

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100126244064.0x000001&indx=1&recIds=ETOCvdc_100126244064.0x000001

A Randomized, Double-Blind, Placebo-Controlled Study of Fentanyl Buccal Tablets for Breakthrough Pain: Efficacy and Safety in Japanese Cancer Patients

Authors: Kosugi, Toshifumi, Hamada, Sasagu, Takigawa, Chizuko, Shinozaki, Katsunori, Kunikane, Hiroshi, Goto, Fumio, Tanda, Shigeru, Shima, Yasuo, Yomiya, Kinomi, Matoba, Motohiro, Adachi, Isamu, Yoshimoto, Tetsusuke, Eguchi, Kenji

Source: In Journal of Pain and Symptom Management June 2014 47(6):990-1000

SPS-6 - WJOG6510G: Randomized phase II of Pmab + IRI vs Cmab + IRI for KRAS WT mCRC previously treated after FU, IRI, and L-OHP

Authors: Hara, Hiroki, Sakai, Daisuke, Takano, Toshimi, Shinozaki, Katsunori, Goto, Masahiro, Taniguchi, Hiroya, Kishimoto, Junji, Boku, Narikazu, Hyodo, Ichinosuke, Muro, Kei

Source: In Annals of Oncology October 2017 28 Supplement 9:ix74-ix74

MO1-19-3Final analysis of survival outcomes in the KSCC1501A trial of up-front therapy for HER2-negative advanced gastric cancer

Authors: Makiyama, Akitaka, Shinozaki, Katsunori, Kashiwada, Tomomi, Kawanaka, Hirofumi, Tanioka, Hiroaki, Okita, Yoshihiro, Fukahori, Masaru, Hayashi, Naomi, Shimokawa, Mototsugu, Saeki, Hiroshi, Oki, Eiji, Baba, Eishi, Baba, Hideo, Mori, Masaki

Source: Annals of oncology. 30(6)

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100097226487.0x000001&indx=1&recIds=ETOCvdc_100097226487.0x000001

REVIVE study: A prospective observational study in chemotherapy (CTx) after nivolumab (NIVO) therapy for advanced gastric cancer (AGC).

Authors: Matsushima, Tomohiro, Narita, Yukiya, Misumi, Toshihiro, Sakamoto, Yasuhiro, Matsuoka, Hiroshi, Tanioka, Hiroaki, Kawakami, Takeshi, Miwa, Hiroto, Shoji, Hirokazu, Ishiguro, Atsushi, Yamada, Takanobu, Fushida, Sachio, Miura, Kou, Shinozaki, Katsunori, Mizukami, Takuro, Nishina, Tomohiro, Moriwaki, Toshikazu, Mitani, Seiichiro, Nakamura, Michio, Muro, Kei

Source: Journal of clinical oncology. 40(4 suppl):257-257

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100152959751.0x000001&indx=1&recIds=ETOCvdc_100152959751.0x000001

A randomized phase III trial of mFOLFOX7 or CapeOX plus bevacizumab versus 5-FU/l-LV or capecitabine plus bevacizumab as initial therapy in elderly patients with metastatic colorectal cancer: JCOG1018 study (RESPECT).

Authors: Hamaguchi, Tetsuya, Takashima, Atsuo, Mizusawa, Junki, Shimada, Yasuhiro, Nagashima, Fumio, Ando, Masahiko, Ojima, Hitoshi, Denda, Tadamichi, Watanabe, Jun, Shinozaki, Katsunori, Baba, Hideo, Asayama, Masako, Fukushima, Tadao, Masuishi, Toshiki, Nakata, Ken, Tsukamoto, Shunsuke, Katayama, Hiroshi, Nakamura, Kenichi, Fukuda, Haruhiko, Kanemitsu, Yukihide

Source: Journal of clinical oncology. 40(4 suppl):10-10

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100152953937.0x000001&indx=1&recIds=ETOCvdc_100152953937.0x000001

Primary tumor location as a predictor of survival in patients with RAS wild-type colorectal cancer who receive molecularly targeted drugs as first-line therapy: a multicenter real-world observational study by the Japanese Society for Cancer of the Colon and Rectum

Authors: Ito, Takahiko, Takashima, Atsuo, Yamazaki, Kentaro, Yukami, Hiroki, Uetake, Hiroyuki, Tsuda, Masahiro, Suto, Takeshi, Moriwaki, Toshikazu, Sugimoto, Naotoshi, Ojima, Hitoshi, Takii, Yasumasa, Yasui, Hisateru, Esaki, Taito, Tsuji, Akihito, Goto, Masahiro, Saruta, Masayuki, Otsu, Satoshi, Shinozaki, Katsunori, Fujiwara, Toshiyoshi, Tamura, Takao

Source: International Journal of Clinical Oncology; Sep2022, Vol. 27 Issue 9, p1450-1458, 9p

Subject Terms: COLORECTAL cancer, COLON cancer, DRUG therapy, OVERALL survival, PANITUMUMAB, RECTAL cancer

WJOG6510G: Randomized phase II of Pmab + IRI vs Cmab + IRI for KRAS WT mCRC previously treated after FU, IRI, and L-OHP

Authors: Hara, Hiroki, Sakai, Daisuke, Takano, Toshimi, Shinozaki, Katsunori, Goto, Masahiro

Source: Annals of oncology. 28(9):SPS-6

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCRN619720634&indx=1&recIds=ETOCRN619720634

Oncolysis of Multifocal Hepatocellular Carcinoma in the Rat Liver by Hepatic Artery Infusion of Vesicular Stomatitis Virus

Authors: Shinozaki, Katsunori, Ebert, Oliver, Kournioti, Chryssanthi, Tai, Yun-Sheng, Woo, Savio L.C ^*

Source: In Molecular Therapy March 2004 9(3):368-376